A Registry of AL Amyloidosis (ReAL)
ConditionAL Amyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorFondazione IRCCS Policlinico San Matteo di Pavia
About this trial
The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
diagnosis of systemic AL amyloidosis;
treatment-naïve (pre-treatment data collected at participating center available for retrospective part);
age ≥18 years;
ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
Disqualifiers
non-AL amyloidosis;
previous treatment for AL amyloidosis.
Trial population
Patients will be entered the database pending on expressing an informed consent of the use of their data for research purposes.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Creation of a registry of patients with AL amyloidosis
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov